More significantly, the study identifies Ang-(1–7)-targeted SNHG14/miR-223-3p as an inhibitor of neuroinflammation in AD and reveals the therapeutic potential of its non-peptide analog AVE0991 (Duan et al., 2021). The gene discussed is ANG; the disease is Alzheimer disease.